Skye Bioscience, Inc. (SKYE)

1.02 +0.04 (+4.08%) USD  |  NASDAQ  |  Jan 14, 14:15
More

Skye Bioscience Net Common Equity Issued (Purchased) (Quarterly)

Net Common Equity Issued (Purchased) (Quarterly) Chart

View Net Common Equity Issued (Purchased) (Quarterly) for SKYE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Quarterly) Benchmarks

View Net Common Equity Issued (Purchased) (Quarterly) Benchmarks
Start Trial
Perspective Therapeutics, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade
Kyntra Bio, Inc. Upgrade
Myomo, Inc. Upgrade